This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Using index levels to time market involves aligning trades with key thresholds while avoiding over-interpretation of minor moves.
28,495 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Jim Cramer won’t touch POET as retail investors drive a volatile rally. This report tracks the catalysts, the bets, a...
A bid for executive clemency by Sam Bankman-Fried sent a sharp, sentiment-driven rally through the FTT token, highlig...
May construction starts fell to a six-year low, tightening supply and heightening buying pressure for home buyers as ...
Rivian shares traded near $14.90 as macro headwinds pressure EV names, while a still-growing VW software venture keep...
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
California lawmakers return from summer break to push condo safety reforms, focusing on a true right-to-repair proces...
Even with a $3 million nest egg, retiring at 50 is not automatic. A rising cost of care, taxes, and the chance of mar...
Lyft delivers a dual narrative after Q4 2025: growing bookings and riders on one hand, while a sharp stock decline an...
A new Redfin analysis using Federal Reserve data shows Americans aged 70-plus now hold a 26% share of U.S. real estat...
Trump Media posted a $405.9 million quarterly loss in Q1 2026, largely tied to unrealized cryptocurrency holdings, ev...
Ryanair stock moved higher after better-than-expected Q4 results and improving profitability. This article breaks dow...